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1  | INTRODUC TION
Chronic pain is generally understood in the biopsychosocial con-
text. It is a multidimensional phenomenon, where psychological 
factors and other comorbidities such as sleep disturbances and 
other pain problems influence pain experience, complicate treat-
ment outcome and contribute to chronicity.1,2 During recent years, 
much effort has been put into developing classification systems to 
help to capture the multidimensional character of chronic pain with 
the purpose, among others, improving the prognostic judgments 
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Abstract
Burning mouth syndrome (BMS) patients are psychologically distressed, but whether 
this associates with symptom severity is unclear. The aim was to investigate the 
association of psychological factors with pain intensity and interference in BMS. 
Fifty-two women (mean age 63.1, SD 10.9) with BMS participated. Pain intensity 
and interference data were collected using 2-week pain diaries. Psychological factors 
were evaluated using Depression Scale (DEPS), Pain Anxiety Symptom Scale (PASS) 
and Pain Vigilance and Awareness Questionnaire (PVAQ). The local ethical commit-
tee approved the study. Patients were divided into groups based on pain severity 
distribution tertiles: low intensity (NRS ≤ 3.7) or interference (NRS ≤ 2.9) (tertiles 1-2, 
n = 35) and moderate to intense intensity (NRS > 3.7) or interference (>2.9) (tertile 
3, n = 17). T test, Wilcoxon's test and Pearson's correlation coefficient were used 
in the analyses. Patients in the highest intensity and interference tertiles reported 
more depression (P = .0247 and P = .0169) and pain anxiety symptoms (P = .0359 
and P = .0293), and were more preoccupied with pain (P = .0004 and P = .0003) than 
patients in the low intensity and interference groups. The score of the pain vigilance 
questionnaire correlated significantly with pain intensity (r = .366, P = .009) and inter-
ference (r = .482, P = .009). Depression (r = .399, P = .003) and pain anxiety symptoms 
(r = .452, P = .001) correlated with pain interference. Symptom severity in BMS as-
sociates with symptoms of psychological distress emphasising the need to develop 
multidimensional diagnostics for the assessment of BMS pain.
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and treatment decisions by clinicians treating chronic pain pa-
tients.3-5 In the simplest form, pain intensity and interference, that 
is how much pain interferences with daily activities, have been 
used to summarise the global severity of chronic pain. In a sem-
inal study on chronic pain patients, increasing pain intensity and 
interference was associated with increased psychosocial impair-
ment and predicted the long-term pain status.6 In oro-facial pain 
research, the pain severity continuum has been shown to have sig-
nificant associations with, for example, psychological symptoms, 
other pain problems and treatment-seeking behaviour,6-9 and to 
have prognostic validity.10
Burning mouth syndrome (BMS) is a chronic, debilitating oro-fa-
cial pain condition that is defined by a burning sensation of the oral 
mucosa without any identifiable oral lesions or other pathology to 
explain the symptoms.11,12 The etiopathogenesis of BMS has long 
been considered enigmatic, but today several lines of evidence sug-
gest a neuropathologic background for the symptoms.13,14 Oral pain 
presents the cardinal symptom of BMS. It is usually described as 
burning in quality15 and as mild to severe in intensity.16 The findings 
from a pain diary study demonstrated, in addition to some diurnal 
pain variation, a considerable inter-individual variation in the inten-
sity (NRS mean 3.1, SD 1.7, range 0.24-8. 22) and interference (mean 
NRS 2.5, SD 1.6, range 0.19-7.96) of BMS pain. As regards pain in-
tensity, most patients reported mild to moderate pain, but a minority 
of patients, 8% to 15%, depending on the time of the day, reported 
severe pain (NRS = />5).15
Historically, much research has been devoted to the role of 
psychological factors in BMS. According to controlled studies, 
depression and anxiety are the most common and the most fre-
quently studied psychological symptoms among BMS patients.17 
Pain-specific psychological variables such as pain anxiety or pain 
hypervigilance, which are suggested to be more relevant than 
general psychological symptoms to the understanding of chronic 
pain,18 have not been studied in BMS. As regards other possible 
pain-related comorbidities, the occurrence of sleep disorders has 
received attention in BMS, and several studies have evidenced a 
decrease in the sleep quality in BMS patients.19-22 However, un-
like in other pain research, scarce attention has been paid to link-
ing psychological or other pain-related symptomatology data to 
self-report of pain severity in BMS. Such information could possi-
bly aid in identifying subgroups of patients with varying prognosis 
and treatment needs.
The aim of the present study was to investigate the association 
of psychological factors, sleep problems and other pain symptoms 
with reported pain intensity and interference in BMS. The specific 
aim was to study whether patients reporting most intensive and in-
terfering pain differ from those with less severe pain symptoms.
2  | METHODS
This was a multicentre study with seven participating centres in 
Finland (for a detailed description see Forssell et al15). The study 
protocol followed principles established in the Declaration of 
Helsinki23 and was approved by the local ethical committee.
All female patients aged 18 years or more who visited the study 
centres during a 1-year period (2010-11) and who had had primary 
BMS symptoms for more than 3-month period were invited to par-
ticipate in the study. The diagnosis of BMS was made by exclusion 
of local and systemic causes of oral burning symptoms (secondary 
BMS) with a thorough clinical examination of the oral mucosa and 
measurement of paraffin-chewing stimulated whole saliva. Smear 
from the oral mucosa was used to diagnose oral candidiasis. Blood 
tests included complete blood count, thyroid-stimulating hormone 
(THS), fasting blood glucose, antinuclear antibody values, as well as 
B12 vitamin and serum folate.
To be included in the study, the patient had to be female, 18 years 
old or older, the BMS pain had to be chronic (over 3 months), and the 
pain had to occur daily or almost daily. Exclusion criteria included 
pathological changes of the oral mucosa, hyposalivation, oral can-
didiasis, nutritional deficiencies and anaemia, abnormal TSH level, 
fasting blood glucose or antinuclear antibody values. All participants 
gave their written informed consent.
At baseline, the patients were asked to fill in a baseline self-re-
port questionnaire including questions on demographic data, 
general health and use of medications. Patients were given a pa-
per-and-pencil pain diary to fill in for fourteen consecutive days. 
Pain intensity and interference on normal activities were calcu-
lated as overall means from the pain diaries filled 3 times a day 
using 0 to 10 NRS scales (intensity: 0 = no pain and 10 = worst 
possible pain, interference: 0 = no pain and 10 = pain present such 
that I can't do anything). The pain diary results concerning pain 
intensity and interference have been published earlier.15 Every 
morning the patients registered in the diary whether they had 
had problems with falling asleep because of the BMS pain (no/
yes) and whether the BMS pain had disturbed their sleep during 
the preceding night (no/yes).
The baseline self-report questionnaire included a question: 
“Have you any other pain problems?” and a pain drawing where pa-
tients were asked to paint the locations of these other pains. In the 
analysis, the number of other pains was used. Furthermore, psycho-
logical factors were evaluated at baseline using Depression Scale 
(DEPS), Pain Anxiety Symptom Scale (PASS) and Pain Vigilance and 
Awareness Questionnaire (PVAQ). These represent current, com-
mon, easy-to-use and statistically sound self-rating scales, depicting 
the areas of interest in this study.
2.1 | DEPS
The self-rating Depression Scale (DEPS) was developed in Finland 
as a method to screen for symptoms of depression in primary care 
patients.24 The psychometric properties of the DEPS have been 
demonstrated and found good.25,26 The DEPS comprises 10 items 
depicting various aspects of depressed mood (item examples: 
During the last month I have “Felt low in energy or slowed down”, 
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“Had feelings of worthlessness”). The items are rated on a Likert 
scale (0 not at all-3 extremely) and a sum score, ranging from 0 to 
30, is calculated. The cut-off score = />9,24 which indicates a pos-
sible depression and a need for further investigation, was used in 
this study.
2.2 | PASS
The Pain Anxiety Symptom Scale-20 (PASS-20) was developed 
by McCracken and Dhingra27 as a self-rating scale to assess pain-
related worry, fear and anxiety. It has been widely used in various 
pain patient groups, and its psychometric properties have been 
confirmed.28 The questionnaire comprises 20 items to be rated on a 
six-point Likert scale (0 never-5 always). In addition to calculating a 
sum score (range 0-100), four subscales depicting different aspects 
of pain-related anxiety and including 5 items each, are formed27,29: 
Fearfulness (item example: “When I feel pain, I think I might be se-
riously ill”), Escape/avoidance (item example: I avoid important ac-
tivities when I hurt”), Cognitive anxiety (item example: I can't think 
straight when I am in pain”) and Physiological anxiety (item example: 
Pain seems to cause my heart to pound or race”). The sum score 
range in each of these subscales is 0-25.
2.3 | PVAQ
A Pain Vigilance and Awareness Questionnaire, PVAQ, developed 
by McCracken,30 has been used in various groups of pain patients. 
Its psychometric properties, construct validity, criterion validity and 
reliability, have been found good.31,32 The 16 items are scored on 
a Likert scale (0 never-5 always). In addition to a sum score (range 
0-80), a two-factor solution demonstrated in previous studies (re-
viewed by Kuntz et al32) omitting two items not loading substan-
tially on any of the factors was used in this study. The first factor 
or subscale, Attention to pain, comprises 8 items (item examples: “I 
pay close attention to my pain”, “I become preoccupied with pain”, 
sum score range 0-40). The second subscale, Attention to changes in 
pain, comprises 6 items (item examples “I quickly notice changes in 
pain,””I know immediately when pain starts or increases” sum score 
range 0-30).
3  | STATISTIC AL METHODS
Descriptive statistics include means or proportions (%) with stand-
ard deviations.
Because there are no universally accepted cut-off points for 
pain intensity or interference,33 patients were divided into tertiles 
according to pain intensity and interference. Dividing patients into 
tertiles according to pain intensity gave a cut-off value of 2.4 for 
pain intensity between the first and the second tertile and 3.7 for 
the second and the third tertile. The corresponding cut-off values 
for pain interference were 1.6 and 2.9. As preliminary statistical 
analyses indicated that the two lowest tertiles did not differ statis-
tically significantly from one another on any of the other variables 
studied, these tertiles were combined in further statistical analyses. 
Thus, the patients were divided into two groups based on pain inten-
sity distribution tertiles: tertile 1-2: mild to moderate pain intensity 
(NRS ≤ 3.7, n = 35) and tertile 3: moderate to intense pain intensity 
(NRS > 3.7, n = 17). Similarly, two groups were formed based on in-
terference: tertile 1-2, slight to moderate interference (NRS ≤ 2.9, 
n = 35), and tertile 3, moderate to severe interference (>2.9) (tertile 
3, n = 17). The two intensity and interference groups were compared 
with each other in the studied parameters using t test, Wilcoxon's 
Test and Fisher's exact test. Pearson's correlation coefficient was 
used to study the correlation between study parameters. Missing 
data were handled by listwise deletion. Statistical analyses were 
done using SAS version 9.4 software (SAS Institute). P-values < .05 
were considered statistically significant.
4  | RESULTS
Fifty-two female patients (mean age 63.1, SD 10.9) with primary 
BMS participated in the study. The mean length of the BMS pain 
was 66.8 months (SD; 59.3, range 6-240 months). Twelve of the pa-
tients had no general health problems. Twenty patients reported 
cardiovascular diseases, eight patients had compensated hypothy-
roidism, one patient diabetes, one epilepsy, and five patients had 
asthma. Six patients had a diagnosed depression. Two patients used 
tranquillisers, six used antidepressants and nine patients used sleep 
medication. Nineteen patients reported other pain problems such 
as headache (six patients), joint pain (seven patients) or fibromyal-
gia (four patients). There were no statistically significant differences 
between the two intensity tertiles or between the two interference 
tertiles as regards the age of the patients or the numbers of patients 
with hypothyroidism, depression, headache, joint pain or fibromy-
algia. Also, the numbers of patients using tranquillisers, antidepres-
sants or sleep medication distributed equally among the studied 
tertile groups.
Completely filled diaries were received from 47 patients. In the 
five incomplete diaries, the maximum of incompletely filled diary 
days was four. Table 1 shows the amount of missing data concerning 
the psychological scales.
Patients reporting more intensive and interfering pain, that is 
those in the highest intensity and interference tertiles, reported 
overall significantly more depression symptoms compared to pa-
tients with less severe symptoms (Table 1). Further, more than half 
of the patients, viz. 9/17, in the highest intensity and interference 
tertiles had DEPS scores at or above the cut-off score for depressive 
symptoms compared with less than a third of the patients, viz. 10/35, 
with lower pain intensity or interference.
The patients in the highest intensity and interference tertiles 
also displayed significantly more pain-related anxiety symptoms 
than those with less severe pain symptoms. Specifically, group 
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differences were noted in two of the subscales, escape-avoidance 
and cognitive anxiety (Table 1).
Patients in the highest intensity and interference tertiles were 
more preoccupied with the pain compared with patients with less 
severe pain. Between-group differences were noted for both of the 
factors of PVAQ, that is attention to pain and attention to changes 
in pain (Table 1).
The correlations between DEPS, PASS and PVAQ sum scores 
were high, varying between r = .46-.59 (P < .001).
The sum score of the PVAQ was found to correlate significantly 
with pain intensity (r = .366, P = .009) and interference (r = .482, 
P = .009). Depression (r = .399, P = .003) and pain anxiety symp-
toms (r = .452, P = .001) correlated with pain interference, but cor-
relations with pain intensity did not reach statistical significance 
(r = .243, P = .082 and r = .269, P = .053 for depression and anxiety, 
respectively).
There was no association between the number of other pains 
and BMS pain intensity or interference (Table 1). Patients reporting 
high pain interference had difficulties in falling asleep because of the 
pain more often, and they also experienced more often pain-related 
sleep disturbances (Table 1).
5  | DISCUSSION
5.1 | Main findings
In accordance with the biopsychosocial model of chronic pain that 
emotional and cognitive factors play a role in pain experience, the 
results of the study demonstrated that BMS patients reporting 
more intensive and interfering pain reported more depressive and 
pain-related anxiety symptoms and more pain hypervigilance com-
pared with patients with less severe pain intensity and interference. 
Patients reporting higher pain interference also reported more pain-
related sleep problems. Depression and pain anxiety were found to 
correlate especially with pain interference, whereas pain hypervigi-
lance correlated also with pain intensity.
Depressive symptoms were prevalent among BMS patients, and 
more than a third of the patients (19/52) had DEPS scores above 
the cut-off score for possible depression. The results are in line with 
previous research indicating that depression is highly prevalent in 
BMS patients.17
As regards pain anxiety and pain hypervigilance, the re-
sults are novel, as these pain-specific psychological factors have 
not earlier been assessed in BMS patients. They are part of the 
fear-avoidance model of chronic pain according to which pain 
initiates a set of emotional, cognitive and behavioural processes, 
which may exacerbate pain and disability.34,35 Symptoms of pain 
anxiety correlate with pain intensity and disability in chronic pain 
patients36 and do so more consistently in comparison with the 
general anxiety symptoms.18 In line, in our study, BMS patients re-
porting most intensive and interfering pain displayed significantly 
more pain anxiety symptoms than those with less severe pain. 
The pain and interference groups differed specifically in respect 
to escape-avoidance (stopping or avoiding activities) and cogni-
tive anxiety (difficulties to concentrate on other things) aspects 
of pain-related anxiety; the more pain and interference, the more 
these types of symptoms. Knowledge of the specific type of pain 
anxiety symptoms may facilitate development of individualised 
treatment interventions.
TA B L E  1   The values (mean, SD) of psychological, comorbid pain and sleep-related characteristics for all patients and for patients divided 
into groups based on pain intensity and interference tertiles
All Pain intensity tertiles Pain interference tertiles
 Mean (SD)
Tertiles 1-2 Tertile 3
P
Tertiles 1-2 Tertile 3
P
NRS ≤ 3.7 NRS > 3.7 NRS ≤ 2.9 NRS > 2.9
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
DEPS (n = 52) 7.9 (6.7) 6.5 (5.6) 10.9 (7.9) .025 6.4 (5.6) 11.1 (7.7) .017
PASS (n = 52) 27.0 (19.1) 23.2 (16.5) 34.9 (18.5) .036 23.1 (16.5) 35.2 (21.8) .029
Fearfulness  6.2 (4.8) 8.5 (6.3) .146 6.3 (4.7) 8.3 (6.5) .198
Escape/avoidance  5.8 (5.0) 9.0 (5.6) .042 5.7 (5.1) 9.2 (5.3) .027
Cognitive anxiety  8.3 (5.2) 12.1 (6.3) .025 8.2 (5.2) 12.3 (6.1) .014
Physiological anxiety  2.9 (4.3) 5.3 (6.2) .102 2.8 (4.3) 5.3 (6.1) .090
PVAQ (n = 50) 46.5 (16.1) 41.0 (14.9) 57.2 (13.1) .000 40.9 (14.5) 57.4 (13.6) .000
Attention to pain  15.9 (8.7) 25.3 (8.6) .001 15.8 (8.6) 25.5 (8.7) .000
Attention to changes in pain  19.9 (6.0) 24.2 (4.1) .009 19.8 (5.8) 24.4 (4.4) .006
N of other pains (n = 48) 1.7 (1.3) 1.8 (1.3) 1.6 (1.4) .699 1.8 (1.3) 1.7 (1.4) .320
Difficulties in falling asleep (% of nights) 
(n = 52)
20.5 (27.8) 13.5 (19.5) 34.9 (36.4) .056 11.7 (17.5) 38.6 (35.9) .012
Disturbed sleep (% of nights) (n = 52) 5.9 (13.4) 4.3 (11.8) 9.3 (16.0) .156 2.5 (5.8) 13.0 (12.5) .029
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Excessive attention to pain or pain hypervigilance has been re-
ported to associate with higher pain intensity, disability and emo-
tional distress in different pain patient populations30,31 and has been 
suggested to influence disability more than other psychological 
factors.37 The findings of the present study showing a significant 
association between pain intensity and interference with pain hy-
pervigilance may indicate that pronounced attention to pain may be 
an important factor also in BMS pain. Both subscales, “attention to 
pain” and “attention to changes in pain”, differed significantly, indi-
cating that the suggestion by Roelofs et al31 to use a total PVAQ sum 
score is justified.
A recent study on pain-related cognitive factors in BMS patients 
focused on pain catastrophising, that is a tendency to magnify the 
threat value of pain stimulus and to feel helpless in the context of 
pain.22 In this study, catastrophising was found to be associated with 
pain experience emphasising the role of maladaptive cognitive re-
sponses in BMS pain.
In addition to pain-related psychological factors, also patients’ 
self-reported pain-related sleep problems were associated with pain 
experience in the present study. Patients reporting high pain inter-
ference reported difficulties in falling asleep more often and expe-
rienced sleep disturbances more often. Two studies assessing sleep 
disturbances with validated sleep scales in BMS patients reported a 
corresponding association.20,22
Much attention has been paid to the frequent co-occurrence and 
overlap of pain syndromes in chronic pain, with consequent pain am-
plification and perpetuation of the pain condition.38 Comorbid pain 
conditions have been reported to be common among patients with 
different oro-facial pain conditions and to correlate with increas-
ing pain severity.9,38,39 To the contrary, a recent systematic review 
found no evidence of an association between BMS and other pain 
symptoms.40 Herein, no association was found between the number 
of other pains and BMS pain severity. The finding may support the 
notion that BMS is a distinct intra-oral disease entity depending on 
specific mechanism at the trigeminal level.40
In the correlation analysis, the studied psychological parameters 
associated more with pain interference, a positive correlation with 
pain intensity was found only for pain hypervigilance. Likewise, no 
correlation was found between psychological symptoms and pain 
intensity in a previous study on the correlation of psychological 
symptoms with pain intensity in BMS patients.41 The findings in BMS 
patients are in keeping with earlier findings of a more strong associa-
tion of cognitive and affective measures to pain interference than to 
pain intensity in different chronic pain patient populations.42,43 The 
statistically significant correlations between the psychological pa-
rameters (DEPS, PASS and PVAQ) suggest that they may be regarded 
as indicators of a more general psychological distress continuum.
5.2 | Methodological considerations
Pain intensity and interference figures were based on prospec-
tive pain diary data.15 Prospective responses are considered more 
accurate compared to retrospective responses, which tend to show 
more inflation.44 The amount of missing data was low; at the most, 
some data were missing from 4 patients (Table 1), supporting the use 
of listwise deletion in the statistical analysis.
The depression questionnaire, DEPS, used in this study was 
developed and validated as a screening instrument for patients in 
primary care,24 while the internationally recommended Depression 
Scales have been developed for psychiatric patients. The validity 
of the commonly used Depression Scales in patients with somatic 
symptoms such as pain has been questioned. For example, sleep dis-
turbance, loss or change of appetite, and fatigability have been re-
garded as “somatic” symptoms which, in the case of somatic illness, 
do not necessarily indicate depression.45-48 DEPS, except for the 
item of sleep problems, does not include any of the”somatic” symp-
toms found problematic in earlier studies on pain patients and is 
therefore probably better suited to depict depression in this patient 
group. Further research is however needed to explore the validity 
and reliability of DEPS in the field of chronic pain. Regardless of the 
assessment method, diagnosing depression in chronic pain remains a 
challenge and requires careful interpretation of symptoms.
In this study, the focus was on symptoms of depression, pain-re-
lated anxiety and attention to pain, all of which present aspects of 
psychological vulnerability to chronic pain. Paying attention in future 
studies also to resilience aspects of pain, such as pain acceptance 
and positive psychological resources, would broaden the picture of 
the role of psychological factors in BMS pain experience.
The cross-sectional nature of the study limits causal interpre-
tation of the relationships between pain intensity and interference 
and psychosocial factors. The most obvious limitation of the pres-
ent study is the modest sample size, which prevented us from using 
more complicated statistical models to study the relative contribu-
tion of different comorbid factors on BMS pain experience.
5.3 | Clinical implications
According to the results of the present study, patients suffering from 
BMS symptoms are not a homogenous group. Patients experiencing 
different levels of symptom severity differed also in terms of comor-
bid symptoms so that patients with high pain intensity and inter-
ference were more psychosocially distressed compared to patients 
with less severe pain. The study thus identified subgroups of BMS 
patients likely having differing prognosis and treatment needs. As 
psychological factors are considered to be highly relevant in terms 
of treatment outcome and prognosis in pain, the prevailing view is 
that they should be addressed as part of the assessment in any pain 
condition.2,49
The findings of the present study are in line with findings 
from other oro-facial pain research,6-9 where pain severity contin-
uum assessments have generally also been used as tools to tailor 
treatments to patients’ symptoms.49,50 Treatment tailoring has so 
far not been applied to the treatment of BMS, which may in part 
explain the modest treatment outcomes achieved by different 
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treatment methods.11 The present results underline the need to 
develop the diagnostics and treatment of BMS in a multidimen-
sional direction.
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